It’s possible to assess dietary compliance from a blood sample - that is useful in controlled dietary intervention studies investigating the health benefits of specific diets, since such studies have mainly relied on the participants’ self-reported dietary intake, which is often biased, making it more difficult to assess the real health benefits.
In the recently published paper using results from the Nordic SYSDIET study, Dr. Matti Marklund and colleagues were able to identify the study participants with the greatest apparent compliance to a healthy Nordic diet by testing for a set of diet-related biomarkers in the blood. The beneficial effects of the diet on cardiometabolic risk factors, such as elevated blood pressure and blood lipids, were also greatest in this group. In all, there were 154 participants in the study.
Dietary biomarkers are compounds related to a certain food or nutrient that are measurable in bodily tissues and fluids, such as blood. In the SYSDIET study , the intervention group was advised to follow a healthy Nordic diet rich in berries, vegetables, fatty fish, canola oil, and whole grains. Several blood biomarkers were assessed to reflect the consumption of different key components of the diet, such as serum alpha linoleic acid as a biomarker of canola oil consumption, EPA and DHA reflecting fatty fish consumption, plasma beta carotene as a biomarker for vegetable intake and plasma alkylresorcinols reflecting whole grain consumption. High-fat dairy intake, which should be low in the healthy Nordic diet, was reflected by serum pentadecanoic acid.
The researchers conclude that when investigating the health effects of whole diets, it’s useful to measure multiple biomarkers reflecting the intake of different components of the diet. This way of assessing compliance also helps to better detect changes in risk factors.
In future studies, the combined use of biomarkers and participants’ dietary self-reports can improve dietary intake estimation and help to better evaluate the impact of the diet. In addition, informing participants that compliance will be assessed by dietary biomarkers might further motivate them to adhere to study diets.
Citation: Marklund M, Magnusdottir OK, Rosqvist F, Cloetens L, Landberg R, Kolehmainen M, Brader L, Hermansen K, Poutanen KS, Herzig KH, Hukkanen J, Savolainen MJ, Dragsted LO, Schwab U, Paananen J, Uusitupa M, Akesson B, Thorsdottir I, Risérus U. A Dietary Biomarker Approach Captures Compliance and Cardiometabolic Effects of a Healthy Nordic Diet in Individuals with Metabolic Syndrome. The Journal of nutrition 07/2014; DOI: 10.3945/jn.114.193771.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Kudos To "The Independent" Newspaper For Debunking Nibiru "Blood Moon" Hoax
- USDA Microbiologist Warns Bacteria In Vaping Products May Be A Health Concern
- Your Microbiome Did Not Cause Your Weight Problem
- 20 Cent School Intervention Stops Unhealthy Weight Gain In Children
- Control Cancer By Making The Tumor Cell Environment Hostile
- Gödel,Frenkel, Kurzweil, and Hawkins on AI
- A Great Blitz Game
- "So your absolutely certain and can absolutely guarantee that its not real mr walker. Charles ..."
- "Great, glad to have helped Michael, thanks :)...."
- "Right. But it can help to pin that down a bit and say what particularly you are worried about...."
- "Interesting Thanks for the helpful information, Robert. You give such insightful and easy to understand..."
- "Okay - there are a lot of urban myths about earthquakes, and these Nibiru people tend to..."
- Breast Cancer: Genomics May Show Where Chemo Might Not Be Needed
- Gallup Poll: Great Example of How to Bias a Social Science Study
- Another Kardashian Craze Debunked
- Fad Friday: Ditch The Body Wrap!
- Commonly Cited Stat of 10 Bacteria for Every 1 Human Cell Is Wrong
- Why The EpiPen And Other Generic Drugs Are So Expensive
- Heart failure in the elderly set to triple by 2060
- Up to 80 percent of heart failure patients denied therapy to reduce hospitalization and death
- Increased risk of death for heart failure patients with each NHS hospital admission
- Nebivolol prevents anthracycline-induced cardiotoxicity
- Traffic accidents increased by 50 percent in patients with implantable cardioverter defibrillator